Citation: | ZHANG Yaqi, HUANG Yanting, GAO Yuan, ZHANG Jianjun. Thermodynamics of baicalein-nicotinamide co-crystallization process[J]. Journal of China Pharmaceutical University, 2015, 46(5): 568-574. DOI: 10.11665/j.issn.1000-5048.20150509 |
[1] |
Lara-Ochoa F, Espinosa-Perez G. Cocrystals definitions[J].Supramol Chem,2007,19(8):553-557.
|
[2] |
Shayanfar A,Asadpour-Zeynali K,Jouyban A.Solubility and dissolution rate of a carbamazepine- cinnamic acid cocrystal[J].J Mol Liq,2013,187:171-176.
|
[3] |
Karki S,Friˇci'c T,Fábián L,et al.Improving mechanical properties of crystalline solids by cocrystal formation:new compressible forms of paracetamol[J].Adv Mater,2009,21(38/39):3905-3909.
|
[4] |
Gao Y,Zu H,Zhang J.Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation[J].J Pharm Pharmacol,2011,63(4):483-490.
|
[5] |
Jung MS,Kim JS,Kim MS,et al.Bioavailability of indomethacin-saccharin cocrystals[J].J Pharm Pharmacol,2010,62(11):1560-1568.
|
[6] |
Trask AV,Motherwell WD,Jones W.Physical stability enhancement of theophylline via cocrystallization[J].Int J Pharm,2006,320(1/2):114-123.
|
[7] |
Liu J,Qiu L,Gao J,et al.Preparation,characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin[J].Int J Pharm,2006,312(1/2):137-143.
|
[8] |
Huang Y,Zhang B,Gao Y,et al.Baicalein-nicotinamide cocrystal with enhanced solubility,dissolution,and oral bioavailability[J].J Pharm Sci,2014,103(8):2330-2337.
|
[9] |
Zhang J,Zu H,Gao Y.Formation thermodynamics of adefovir dipivoxil-saccharin co-crystals[J].Acta Phys-Chim Sin(物理化学学报),2011,27(3):547-552.
|
[10] |
Liu J,Zheng XQ,Chen LF,et al.Effect of polymers on the formation thermodynamics of adefovir dipifoxil-saccharin cocrystal[J].J China Pharm Univ(中国药科大学学报),2015,46(2):194-200.
|
[11] |
Croker DM,Foreman ME,Hogan BN,et al.Understanding the p-toluenesulfonamide/ triphenylphosphine oxide crystal chemistry:a new 1∶1 cocrystal and ternary phase diagram[J].Cryst Growth Des,2012,12(2):869-875.
|
[12] |
Childs SL,Rodríguez-Hornedo N,Reddy LS,et al.Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine[J].CrystEngComm,2008,10(7):856-864.
|
[13] |
Nehm SJ,Rodríguez-Spong B,Rodríguez-Hornedo N.Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation[J].Cryst Growth Des,2006,6(2):592-600.
|
[14] |
Schartman R.On the thermodynamics of cocrystal formation[J].Int J Pharm,2009,365(1/2):77-80.
|
[15] |
Ainouz A,Authelin JR,Billot P,et al.Modeling and prediction of cocrystal phase diagrams[J].Int J Pharm,2009,374(1/2):82-89.
|
[16] |
Ma K,Zhang Y,Kan H,et al.Thermodynamic and kinetic investigation on the crucial factors affecting adefovir dipivoxil-saccharin cocrystallization[J].Pharm Res,2014,31(7):1766-1778.
|
[17] |
Zhang S,Rasmuson AC.Thermodynamics and crystallization of the theophylline-glutaric acid cocrystal[J].Cryst Growth Des,2013,13(3):1153-1161.
|
[1] | CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301 |
[2] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[3] | TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405 |
[4] | SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402 |
[5] | CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103 |
[6] | WANG Letian, WANG Jinglin, LIU Hongwu, GE Ying, LI Yuyan, XU Qingxiang. Process in targeted contrast agents for cancer imaging[J]. Journal of China Pharmaceutical University, 2017, 48(6): 635-645. DOI: 10.11665/j.issn.1000-5048.20170602 |
[7] | SHANG Yunkai, JU Caoyun, XIE Daping, ZHANG Can. Preparation and characterization of tumor targeting doxorubicin liposomesmodified via click chemistry[J]. Journal of China Pharmaceutical University, 2016, 47(6): 708-713. DOI: 10.11665/j.issn.1000-5048.20160613 |
[8] | XU Yuhong, CAO Jing. Perspectives on targeted nano-drug carriers for tumor treatment[J]. Journal of China Pharmaceutical University, 2013, 44(6): 494-503. DOI: 10.11665/j.issn.1000-5048.20130602 |
[9] | SHI Yongping, SU Zhigui, XIAO Yanyu, SUN Minjie, PING Qineng, ZONG Li. Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor[J]. Journal of China Pharmaceutical University, 2013, 44(4): 321-327. DOI: 10.11665/j.issn.1000-5048.20130407 |
[10] | LI Sai, XIAO Yan-yu, SU Zhi-gui, SHI Lu, PING Qi-neng, ZHANG Can. Preparation of BSA-coated cationic nanostructure lipid carriers and pharmacokinetics and biodistribution after intravenous injection[J]. Journal of China Pharmaceutical University, 2012, 43(5): 406-411. |